Intelligent Bio Solutions (INBS) Net Cash Flow (2020 - 2025)

Intelligent Bio Solutions' Net Cash Flow history runs 6 years deep, the most recent figure standing at $551841.0 for Q1 2025.

• In Q1 2025, Net Cash Flow fell 93.37% year-over-year to $551841.0; the TTM figure through Jun 2025 stood at -$3.5 million (down 184.12% YoY), while the FY2023 annual figure was -$6.6 million, down 56.58% from the prior year.
• Net Cash Flow was $551841.0 for Q1 2025 at Intelligent Bio Solutions, up from -$1.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $8.3 million in Q1 2024 to a low of -$5.7 million in Q1 2021.
• Historically, Net Cash Flow has averaged -$1.1 million across 5 years, with a median of -$1.6 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow sank 2955.07% in 2022, then soared 1427.71% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$1.4 million in 2021, then tumbled by 81.83% to -$2.6 million in 2022, then fell by 10.69% to -$2.9 million in 2023, then soared by 40.99% to -$1.7 million in 2024, then soared by 132.6% to $551841.0 in 2025.
• The last three Net Cash Flow figures came in at $551841.0 (Q1 2025), -$1.7 million (Q4 2024), and -$2.3 million (Q3 2024), per Business Quant data.